SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?


To: betty moyers who wrote (18442)1/31/1999 10:53:00 PM
From: VLAD  Read Replies (2) | Respond to of 23519
 
betty,

According to my sources, Charlie O of PW will be issuing a report on Vivus early this week.

He will reiterate his strong buy rating pointing out some of the positives such as Vivus' ability to clean up its balance sheets and also the fact that although Q1 may be ???, a return to significant profitability is but one domestic partner away.

I think that LW did make it clear that based on Vivus' ability to maintain expenses and preserve cash, they are ready and willing only to sign a favorable deal. It is my understanding that LW has offers on his desk that he can sign at any time but he wants to wait for A/Z to get over the merger stuff and sign a deal that will ultimately be good for both Vivus and A/Z(in the long term if you know what I mean).

Keep the faith.